Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michael Schulewski
Institution:
Rutgers, The State University of New Jersey
Observed institution:
Rutgers, The State University of New Jersey
ORCID:
0009-0006-7676-907X
Observed ORCID:
0009-0006-7676-907X
OpenAlex ID:
A5146670656
Concurrent Gabapentin and Dihydropyridine Calcium Channel Blocker Use and Risk of Incident Dementia: An Active-Comparator Cohort Study
2026
·
James W. Green
, Luciana Mascarenhas Fonseca
, et al.
·
medRxiv
·
2
PDF
Do Cognitive Symptoms Improve When Gabapentin and Dihydropyridine Calcium Channel Blocker Therapy Are Stopped? A Self-Controlled Case Series
2026
·
James W. Green
, Joshua Kaplan
, et al.
·
medRxiv
·
1
PDF
Letter to the Editor for “Evaluating Pharmacogenomic Prescription Data in the Military Health System”: Medication-Induced CYP2D6 Inhibition Reveals a Screening Gap in Proxy-Defined Ibogaine Candidates
2026
·
James Green
, Paul Hartin
, et al.
·
Military Medicine
Does Medication Order Matter? Incident Dementia Risk When Gabapentin Is Added to Prior Dihydropyridine Calcium Channel Blocker Therapy: An Active-Comparator Cohort Study in Hypertensive Adults
2026
·
James W. Green
, Joshua Kaplan
, et al.
·
medRxiv
Chronic Kidney Disease Amplifies Gabapentin-Associated Dementia Risk in Non-Dialysis Patients: Findings Consistent with a Renal Pharmacokinetic Vulnerability
2026
·
James Green
, Laura D. Byham-Gray
, et al.
·
medRxiv
PDF
Show more works
View as search
Works count:
5
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type